
<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare</provider_name><provider_url>https://ceptonstrategies.com/en</provider_url><author_name>Marc-Olivier B&#xE9;vierre</author_name><author_url>https://ceptonstrategies.com/en/author/marc-olivier/</author_url><title>The future of IVDs: important regulatory changes will soon redistribute the cards in the EU &#x2013; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="MoHPFZ7vZZ"&gt;&lt;a href="https://ceptonstrategies.com/en/2523/"&gt;The future of IVDs: important regulatory changes will soon redistribute the cards in the EU&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://ceptonstrategies.com/en/2523/embed/#?secret=MoHPFZ7vZZ" width="600" height="338" title="&#x201C;The future of IVDs: important regulatory changes will soon redistribute the cards in the EU&#x201D; &#x2014; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare" data-secret="MoHPFZ7vZZ" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://ceptonstrategies.com/wp-content/uploads/2017/12/AAIAAQDGAAoAAQAAAAAAAA05AAAAJDUxYmNjODZhLTkwYWYtNDZmMS04M2FlLWEwMGRiYTc3NDgxOQ.png</thumbnail_url><thumbnail_width>678</thumbnail_width><thumbnail_height>365</thumbnail_height><description>With the new European in vitro Diagnosis Device Regulation (IVDR), published in May 2017 [1], but fully in place in 2022, the rules will change for IVD players in Europe. American companies will feel more at home due to the system becoming aligned with that in the US, in addition to having the possibility to [&hellip;]</description></oembed>
